Regular Article
The Interferon Inducible Autoantigen, IFI 16: Localization to the Nucleolus and Identification of a DNA-Binding Domain

https://doi.org/10.1006/bbrc.1995.2269Get rights and content

Abstract

The human IFI 16 gene encodes a nuclear protein whose expression is associated with activation and differentiation of cells of the myeloid lineage, and which has recently been postulated to be a frequent target of human autoantibodies. We have used a unique monoclonal antibody in immunofluorescence studies to define the intranuclear distribution of IFI 16 antigen in primary human leukocyte sub-populations. We demonstrate that IFI 16 is expressed both within the nucleoli and nucleoplasm of mononuclear cells, but is not present in granulocytes. IFI 16 expression correlated with that of the known nucleolar antigen B23, suggesting that the function of IFI 16 is restricted to cells that have nucleoli and therefore are not terminally differentiated. These findings were supported by immunofluorescence studies in IFN-γ-stimulated HL-60 cells and by biochemical fractionation of Daudi nuclear extract. IFI 16 was extracted from whole nuclei at approximately 200-300mM NaCl, within the range described for known transcription factors. Together with our previous findings, these results support a possible role of IFI 16 in binding nucleic acid in vivo. Furthermore, a DNA-binding site was localized within a fusion protein containing the amino-terminal 159 amino acids. As the nucleic acid-binding domains of several proteins are targeted by autoantibodies in SLE, this region may be of significance in the pathogenesis of autoimmune disease.

References (0)

Cited by (56)

  • Herpes Simplex Viruses Type 1 and Type 2

    2022, Encyclopedia of Infection and Immunity
  • The Antiviral Apparatus: STING and Oncolytic Virus Restriction

    2019, Molecular Therapy Oncolytics
    Citation Excerpt :

    For the canonical pathway, instead of placing IFI16 in the cytosolic role of STING activation, Diner suggested that IFI16 might operate in a purely nuclear role, as a downstream effector of IRF3. The seemingly variable behavior of IFI16 during DNA virus infection is consistent with its role as a functionally diverse gene product whose localization is cell-type specific and thus influenced by a range of conditions, including gene polymorphisms, post-translational modifications, hormonal regulation, and protein-protein interactions.35–40 Similarly, cGAS function and cellular localization may also vary.

  • IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases

    2016, Ageing Research Reviews
    Citation Excerpt :

    However, the role of extracellular and “exosomal” IFI16 protein remains unknown. Earlier studies had predicted binding of IFI16 protein to DNA (Dawson and Trapani, 1995b). Accordingly, the IFI16 protein was identified as a cytosolic sensor for double-stranded DNA (DNA) (Unterholzner et al., 2010).

  • Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity

    2015, Cytokine and Growth Factor Reviews
    Citation Excerpt :

    The IFI16 protein was discovered two decades ago as a protein constitutively expressed in the nucleus and nucleoli of lymphoid cells that can be induced by Interferons in myeloid cells [1–3].

  • Innate Recognition of Alphaherpesvirus DNA

    2015, Advances in Virus Research
  • IFI16: At the interphase between innate DNA sensing and genome regulation

    2014, Cytokine and Growth Factor Reviews
    Citation Excerpt :

    IFI16 was first described in lymphoid cells in 1992 and subsequently shown to be associated with myeloid cell differentiation [7,8]. Dawson and Trapani were the first to propose that IFI16 could bind nucleic acids [9] and they characterized a DNA binding domain within the C-terminal region of the IFI16 protein [10]. Today IFI16 is clustered into the PYHIN family of proteins defined by an N-terminal PYRIN domain (PYD), involved in homotypic protein–protein interactions, and one or two C-terminal DNA binding HIN domains (Fig. 2A).

View all citing articles on Scopus
View full text